4607 |
STEMI with MVD: An Ongoing Battle for the Optimal Treatment Strategy |
Neal S. Kleiman |
Apr. 28. 18 |
4606 |
Stable CAD & PAD: COMPASS Trial - Will It Change Practice? |
David Joel Cohen |
Apr. 28. 18 |
4605 |
DAPT Dilemmas in ACS: Where to Go - Shorter vs. Longer Durations? |
Tullio Palmerini |
Apr. 28. 18 |
4604 |
Non-Invasive FFR Assessment |
William F. Fearon |
Apr. 28. 18 |
4603 |
Implications of Hospital-Level Variation in FFR Severity on Cost Effectiveness |
Nils Johnson |
Apr. 28. 18 |
4602 |
How About Integrated Use of Resting Pd/Pa and FFR? |
Jung-Min Ahn |
Apr. 28. 18 |
4601 |
FFR Is Still Standard! |
William F. Fearon |
Apr. 28. 18 |
4600 |
iFR Is Enough! |
Hitoshi Matsuo |
Apr. 28. 18 |
4599 |
Similarities and Dissimilarities of FFR, iFR and Resting Pd/Pa |
Bon-Kwon Koo |
Apr. 28. 18 |
4598 |
[Guiding Coronary Intervention] Imaging Guidance for Treatment of In-stent Restenosis |
Gary S. Mintz |
Apr. 28. 18 |